Verrica Pharmaceuticals (VRCA) Research & Development (2021 - 2025)
Historic Research & Development for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to $2.2 million.
- Verrica Pharmaceuticals' Research & Development fell 831.6% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 million, marking a year-over-year decrease of 5308.28%. This contributed to the annual value of $11.8 million for FY2024, which is 4166.05% down from last year.
- Per Verrica Pharmaceuticals' latest filing, its Research & Development stood at $2.2 million for Q3 2025, which was down 831.6% from $1.8 million recorded in Q2 2025.
- In the past 5 years, Verrica Pharmaceuticals' Research & Development ranged from a high of $6.5 million in Q3 2023 and a low of $1.2 million during Q4 2024
- Its 5-year average for Research & Development is $3.5 million, with a median of $3.3 million in 2024.
- In the last 5 years, Verrica Pharmaceuticals' Research & Development soared by 13417.27% in 2023 and then crashed by 7804.51% in 2024.
- Verrica Pharmaceuticals' Research & Development (Quarter) stood at $3.4 million in 2021, then fell by 9.8% to $3.0 million in 2022, then skyrocketed by 75.69% to $5.3 million in 2023, then crashed by 78.05% to $1.2 million in 2024, then soared by 88.78% to $2.2 million in 2025.
- Its last three reported values are $2.2 million in Q3 2025, $1.8 million for Q2 2025, and $2.3 million during Q1 2025.